LEUPROLIDE

Leuprolide Acetate is presented as a hormonal preparation and belongs to the class of gnRH agonist antineoplastic (hormonal). Its standard indications include advanced prostate cancer and hormone-sensitive conditions, as determined by a prescribing clinician.

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.